Abstract | BACKGROUND: Cutaneous adverse events associated with the use of epidermal growth factor receptor inhibitors, such as cetuximab are relatively common. Although there are reports about possible treatments for acne or acneiform lesions induced by cetuximab, there are only few reports of prospective studies. OBJECTIVE: The aim of the study was to analyze the efficacy of varius treatment modalities and their combinations in patients with acneiform eruptions caused by cetuximab. PATIENTS AND METHODS: RESULTS: CONCLUSION: The results of our short case study may indicate that a combitation therapy of oral tetracyclin and topical ketokonazole is most effective in the therapy of patients with acneiform eruptions caused by cetuximab.
|
Authors | Satoshi Nakamura, Yoshio Hashimoto, Kaoru Nishi, Tosihiro Mizumoto, Hidetoshi Takahashi, Hajime Iizuka |
Journal | Journal of dermatological case reports
(J Dermatol Case Rep)
Vol. 8
Issue 1
Pg. 16-9
(Mar 31 2014)
ISSN: 1898-7249 [Print] Poland |
PMID | 24748906
(Publication Type: Case Reports)
|